Guo Jun, Zhao Chunting, Yao Ruyong, Sui Aihua, Sun Lingjie, Liu Xiaodan, Wu Shaoling, Su Zhan, Li Tianlan, Liu Shanshan, Gao Yan, Liu Jiaxiu, Feng Xianqi, Wang Wei, Zhao Hongguo, Cui Zhongguang, Li Guanglun, Meng Fanjun
College of Medicine, Qingdao University, Qingdao, Shandong 266071, P.R. China.
Department of Hematology, People's Hospital of Rizhao, Rizhao, Shandong 276800, P.R. China.
Exp Ther Med. 2019 Mar;17(3):1593-1600. doi: 10.3892/etm.2019.7153. Epub 2019 Jan 4.
Three dimensional (3D) culture has gradually become a research hotspot in the field of drug screening, stem cell research, and tissue engineering due to its more physiological-like morphology and function. In this study, we compared the differences of cell proliferation, population, protein expression and chemoresistance profiles between two dimensional (2D) and 3D culture of acute lymphoblastic leukemia (ALL) Jurkat cell line. Polycaprolactone (PCL) is used for 3D culture owing to its biochemical properties and compatibility. Culturing of ALL Jurkat cell line in collagen type I coated polycaprolactone scaffold for 168 h increased cell proliferation, attachment, as well as the drug resistance to cytarabine (Ara-C) and daunorubicin (DNR) without changing the original CD2CD3CD4CD8CD34CD45 phenotype, compared to uncoated PCL scaffold and tissue culture plate systems. Molecularly, increased chemoresistance is associated with the upregulation of discoidin domain receptor 1 (DDR1) and transcription factor STAT3. Inhibition of DDR1 activity by DDR1-specific inhibitor DDR-IN-1 accelerated cell death in the presence of Ara-C, DNR or their combination. These results demonstrated that 3D culture enhances chemoresistance of ALL Jurkat cell line by increasing DDR1 expression. Importantly, the cell adhesion-mediated drug resistance induced by DDR1 in the scaffold was similar to the clinical situation, indicating the 3D culture of cancer cells recapitulate the tumor environment and this platform can be used as a promising pre-clinic drug-screen system.
由于其更接近生理状态的形态和功能,三维(3D)培养已逐渐成为药物筛选、干细胞研究和组织工程领域的研究热点。在本研究中,我们比较了急性淋巴细胞白血病(ALL)Jurkat细胞系二维(2D)和三维(3D)培养之间细胞增殖、群体、蛋白质表达和化疗耐药谱的差异。聚己内酯(PCL)因其生化特性和相容性而用于三维培养。与未包被的PCL支架和组织培养板系统相比,将ALL Jurkat细胞系在I型胶原包被的聚己内酯支架中培养168小时可增加细胞增殖、附着以及对阿糖胞苷(Ara-C)和柔红霉素(DNR)的耐药性,且不改变原始的CD2CD3CD4CD8CD34CD45表型。在分子水平上,化疗耐药性增加与盘状结构域受体1(DDR1)和转录因子STAT3的上调有关。DDR1特异性抑制剂DDR-IN-1抑制DDR1活性可在存在Ara-C、DNR或其组合的情况下加速细胞死亡。这些结果表明,三维培养通过增加DDR1表达增强了ALL Jurkat细胞系的化疗耐药性。重要的是,DDR1在支架中诱导的细胞黏附介导的耐药性与临床情况相似,表明癌细胞的三维培养概括了肿瘤环境,并且该平台可作为一个有前景的临床前药物筛选系统。